No profile data available.
Genix Pharmaceuticals Corporation (GENPF) is a healthcare company in the nutritional and natural health products industry, based in Vancouver, Canada.
It reported revenue of 0 CAD for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -335,055 CAD. In Q1 2026 (the quarter ended January 31, 2026) revenue was 0 CAD. Its market capitalization was $844,893 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended October 31, 2025; market data as of October 8, 2026.
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops.
Genix Pharmaceuticals reported 0 CAD in revenue for fiscal year 2025, down 100.0% from 4,051 CAD in fiscal year 2024. In Q1 2026 revenue was 0 CAD.
$844,893 as of October 8, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Herborium Group, Inc. (HBRM), Halberd Corporation (HALB), Kaya Holdings, Inc. (KAYS), Pond Technologies Holdings Inc. (PNDHF).